Many companies are in the midst of preparing their year-end Annual Reports on Form 10-K and looking ahead to their annual meeting of shareholders.

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

Life sciences company Azenta (NASDAQ:AZTA) reported in Q4 CY2024, but sales fell by 4.4% year on year to $147.5 million. Its ...